One Drug, Many Targets: Is This The Future?
Links shared publicly online about this topic.
- 331total visits
One Drug, Many Targets: Is This The Future?
View full resource at medicalnewstoday.com
Tags: HIV Medication, Cancer, Drug, Viracept
Most Recently Shared on April 28, 2011 at 10:37 pm By:
One Drug, Many Targets: Is This The Future?: Potential molecular targets of the anti-HIV drug nelfinavir have been iden.. http://dld.bz/Yjq7
Also Shared By:
Qiagen Gains Approval in Japan for EGFR Companion Diagnostic, Rights to Cancer Biomarkers | IVD Technology
ivdtechnology.com — “Qiagen announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs. The approval is a milestone in Qiagen's Personalized Healthcare strategy, as Japan is one of the world's largest markets for companion diagnostic tests.” View full resource at ivdtechnology.com
Most Recently Shared on January 10, 2012 at 6:56 pm By:
IVD Technology Health Magazine
Qiagen Gains Approval in Japan for EGFR Companion Diagnostic, Rights to Cancer Biomarkers http://t.co/L0pEGjEk
Qiagen Receives Regulatory Approval in Japan for EGFR Companion Diagnostic to Guide Cancer Treatments | Biomarker Commons
biomarkercommons.org — “Qiagen today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.” View full resource at biomarkercommons.org
Most Recently Shared on January 10, 2012 at 12:53 pm By:
MIT's Langer discusses targeted drug delivery - FierceDrugDelivery
fiercedrugdelivery.com — “Legendary MIT Professor Robert Langer recently talked to EarthSky about targeted drug delivery and the future of medicine. Among the many activities going on in the Langer Lab is the development of Read more >>” View full resource at fiercedrugdelivery.com
Most Recently Shared on July 13, 2011 at 12:21 pm By:
MIT's Langer discusses targeted drug delivery. http://bit.ly/oAK58R
Personalised Cancer Medicine MetMAb Gives Hope For The Future Treatment Of Non-small Cell Lung Cancer - QualityPoint Technologies
qualitypointtech.net — “Roche today announced final results from a randomised, multicentre, double-blind Phase II study with its investigational personalised medicine, MetMAb, in people with previously-treated advanced non-small cell lung cancer (NSCLC). MetMAb is a one-armed investigational antibody designed to target Met, a protein (or receptor) associated with a poor outcome in many cancers...” View full resource at qualitypointtech.net
Most Recently Shared on May 19, 2011 at 3:00 am By:
Personalised Cancer Medicine MetMAb Gives Hope For The Future Treatment Of Non-small Cell Lung Cancer: Roche today... http://bit.ly/kCNAkj
One drug, many targets: Finding molecular targets of an HIV drug used in cancer therapy
medicalxpress.com — “Researchers at the University of California, San Diego and Hunter College of the City University of New York (CUNY) have identified potential human molecular targets of the anti-HIV drug Nelfinavir, which may explain why the drug is also effective as a cancer therapy. Their study will be published in ...” View full resource at medicalxpress.com
Most Recently Shared on April 28, 2011 at 10:00 pm By:
One drug, many targets: Finding molecular targets of an HIV drug used in cancer therapy http://bit.ly/jLqcH0
New Targets Found for Aggressive Breast Cancer | Bioscience Technology Online
biosciencetechnology.com — “With currently available early-detection methods for breast cancer, many people can be treated successfully. But for the 20 percent of patients with so-called triple-negative breast cancer, the outcome is bleak. Now, however, researchers from Harvard Medical School and Baylor College of Medicine have identified a critical molecular component to the disease, one that suggests potential therapies involving combinations of FDA-approved, readily available drugs.” View full resource at biosciencetechnology.com
Most Recently Shared on March 24, 2011 at 3:25 pm By:
Men For A Cause (TM) Health Organization
New Targets Found for Aggressive Breast Cancer http://ping.fm/GvBVg
A Dying Wish - Forbes.com
forbes.com — “A targeted cancer drug kept me alive for nine years. Congress must ensure that future patients get the same chance to live.” View full resource at forbes.com
Most Recently Shared on February 10, 2011 at 2:03 am By:
westr Doctor, Health Social Media, and PhD
RT @SusanDElia: One patient's dying wish: A law to make personalized medicine a reality http://bit.ly/hZrJEy v @matthewherper @Forbes #pm101
New agent chokes off energy supply, kills cancer cells
sciencedaily.com — “Researchers have designed an experimental drug that chokes off the energy supply of cancer cells. OSU-CG12 is one of a new class of anticancer drugs called energy-restriction mimetic agents. Energy restriction offers a powerful new treatment strategy because it targets a survival mechanism used by many types of cancer. The findings show that it is possible to design energy-restricting drugs, which may also be useful for treating metabolic syndromes, diabetes, cardiovascular disease and obesity.” View full resource at sciencedaily.com
Most Recently Shared on April 10, 2010 at 6:34 pm By:
New experimental drug cokes off sugar supply to cancer cells. http://bit.ly/aCcZJi
Advertisement
MNT HIV/Aids
@mnt_hivaids
One Drug, Many Targets: Is This The Future? http://mnt.to/3V3j #hivaids
1 year ago...